drugset / Trial / NCT04356352

Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain

NCT04356352

Phase 2/3 Terminated 33 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary hypothesis is that esmolol and lidocaine, when given without the use of a tourniquet, provide relief of propofol injection pain that is superior to placebo when assessed using the propofol pain scoring tool

Timeline

Start
2020-09-09
Primary completion
2023-08-25
Completion
2023-08-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esmolol Other / unclassified 0.5 mg/kg
Comparator Lidocaine Other / unclassified 1 mg/kg

Indications

No indication recorded.